GlaxoSmithKline plc and Royal Dutch Shell plc: 2 income champions to protect you from Brexit risks

GlaxoSmithKline plc (LON: GSK) and Royal Dutch Shell Plc (LON: RDSB) are two companies that could be immune to Brexit risks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There’s one concern dominating the minds of investors at the moment and that’s Brexit. Indeed, if Britain votes to leave the EU on 23 June, the country will be subject to a multi-year period of uncertainty, and it’s this uncertainty that will cause investors the most pain.

To protect against uncertainty and any adverse effects that may come as a result of Britain’s decision to leave the EU, investors could look to large international firms with well-covered dividend yields and well-positioned to succeed in any economic environment.

Defensive business 

GlaxoSmithKline (LSE: GSK) is one such company. The pharmaceuticals giant is a world leader in the production of consumer pharmaceutical products, such as over-the-counter medicines, toothpaste and painkillers. What’s more, the group has a large vaccines division as well as a stake in ViiV Healthcare, a joint venture dedicated to delivering advances in treatment and care for people living with HIV. It’s extremely unlikely that any one of these businesses will see a sudden drop-off in demand for their products in the event of a Brexit.

Moreover, this year Glaxo is on track to report its first year of earnings growth since 2011, so there’s already a significant amount of positive sentiment surrounding the group. City analysts expect the company to report earnings growth of 16% this year, followed by growth of 5% for 2017.

Management has already come out to confirm it’s on track to meet this target. In fact, the first quarter of 2016 was one of the most impressive in several years for the company. Sales increased by 11%, to £6.2bn and earnings per share, excluding exceptional items and adjusted for currency, rose 8% to 19.8p. Shares in Glaxo currently trade at a forward P/E of 15.9 and support a dividend yield of 5.7%.

Global oil company 

Royal Dutch Shell (LSE: RDSB) is another large international company that’s unlikely to be significantly affected by a leave vote. As one of the largest oil traders in Europe and one of the biggest integrated oil companies in the world, Shell is a vital part of the global economy. 

This means that the group is likely to continue to churn out returns for investors no matter what the future holds for the UK economy.

Over the next few years, Shell’s earnings should climb steadily higher as the company continues its integration of recently acquired BG Group and cuts costs further to deal with the slump in oil prices. Asset sales should bolster the enlarged group’s balance sheet while improving margins as low-return assets are sold off.

Shares in Shell currently trade at a forward P/E of 23.7 and support a dividend yield of 7.2%. Management has announced its commitment to the dividend for the foreseeable future so a payout should be secure no matter what the outcome on 23 June.

Rupert Hargreaves owns shares of GlaxoSmithKline and Royal Dutch Shell B. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Santa Clara offices of NVIDIA
Investing Articles

£5,000 invested in Nvidia stock 6 months ago is now worth…

Nvidia stock's taking a breather at the moment. But it could be getting ready for its next move higher, says…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

I hold Lloyds. Is it madness to buy Barclays shares too?

Harvey Jones is keen to buy Barclays shares but wonders whether he's simply doubling down, given that he already holds…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

It’s time we all took a long, cold look at the Lloyds share price

The Lloyds share price has been good to Harvey Jones, making him a huge fan of the FTSE 100 bank.…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett didn’t retire early. But could his investing wisdom help you do so?

Warren Buffett's wisdom from decades of stock market investing is actionable even for a modest investor who simply aims to…

Read more »

Young female hand showing five fingers.
Investing Articles

5 compelling investment ideas for a Stocks and Shares ISA in 2026

Edward Sheldon discusses some ideas to consider for a Stocks and Shares ISA and highlights a UK stock that could…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Is this the best time to buy shares in a long time?

Earlier this week, Bill Ackman stated on X that this is the best time to buy shares in a long…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

£1,000 buys 35 shares in an incredibly reliable FTSE 100 dividend stock

Despite falling 72% from their highs, shares in this FTSE 100 company have been an incredibly reliable source of dividend…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This is what Warren Buffett has to say about passive income — and I’m listening!

While searching for new ways to earn passive income, our writer takes to heart sage advice from the Oracle of…

Read more »